DP
Therapeutic Areas
Kuros Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MagnetOs Granules (PLF Study) | Instrumented Posterolateral Spinal Fusion | Level I Clinical |
| MagnetOs Putty (Lumbar Interbody Study) | Lumbar Interbody Fusion for Degenerative Disease | Clinical Study |
| MagnetOs Putty (Lumbar Interbody Review) | Lumbar Interbody Fusion for Degenerative Disc Disease | Clinical Review |
| MagnetOs Easypack Putty (TLIF Review) | Transforaminal Lumbar Interbody Fusion | Clinical Review |
| Project Fusion | Spine, Extremities, Trauma, Oncology (Evidence Generation) | Research Program |
Leadership Team at Kuros Biosciences
CF
Chris Fair
Chief Executive Officer
PD
Prof. Dr. Joost de Bruijn
Executive Director and President, Innovation & Strategy
DG
Daniel Geiger
Chief Financial Officer
SM
Sjoerd Musters
Chief Operating Officer
JG
John Griffin
Chief Business Officer
GJ
G. Joseph (Joe) Ross
Senior Vice President, Marketing and Business Development
LR
Laura Rosa
Senior Vice President, Global Human Resources
TA
Todd A. Stohler
Vice President, U.S. Sales
PC
Professor Clemens van Blitterswijk
Chairman of the Board